Sorry, you need to enable JavaScript to visit this website.

PREMARIN® INTRAVENOUS (conjugated estrogens) Overdosage


Overdosage of estrogen may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness and fatigue, and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of Premarin therapy with institution of appropriate symptomatic care.

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event


Please enter your search term(s) for PREMARIN® INTRAVENOUS